HIGHLIGHTS
- who: Prognosis and collaborators from the Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China have published the Article: The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy, in the Journal: Journal of Immunology Research of 23/01/2023
- what: This study is aimed at comprehensively delineating the expression profile of ARMCX1 in GC patients, to clarify its associations with clinical data and patient prognosis, as well as the potential mechanisms by which ARMCX1 affects GC progression. In the present study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.